Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival

Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival

Rafael Cerón,1,2 Adolfo Martínez,2 Christian Ramos,3 Adrián De la Cruz,2 Anel García,2 Iveth Mendoza,2 Goujon Palmeros,2 Efreen Horacio Montaño Figueroa,3 Juan Navarrete,4 Silvia Jiménez-Morales,5 Carlos Martinez-Murillo,3 Irma Olarte2 1Posgrado en Ciencias Biológicas, Biomedicina, UNAM, CDMX, Méxic...

Full description

Bibliographic Details
Main Authors: Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:OncoTargets and Therapy
Subjects:
biomarkers
ctcs
lymphoma
liquid biopsies.
Online Access:https://www.dovepress.com/overexpression-of-bcl2-bcl6-vegfr1-and-twist1-in-circulating-tumor-cel-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/overexpression-of-bcl2-bcl6-vegfr1-and-twist1-in-circulating-tumor-cel-peer-reviewed-fulltext-article-OTT

Similar Items